Fotini Karakontaki PNEUMOLOGIST - TB SPECIALIST

Education & Academic Qualifications

Graduation from Medical School (MD degree): University of Patras, Greece (2003)
Fellowship in Pulmonology (2013)
PhD (2014): University of Athens Medical School, grade “Excellent”:
Topic of research: chronic obstructive pulmonary disease
Postgraduate training in emergency medicine (2013-2014)
1st International ACCP Pulmonary Board Preparation and Review Course. Athens, 2009.
ACCP Pulmonary Board Preparation and Review Course, San Antonio Texas, 2011
European Resuscitation Council BLS/AED provider course, November 2011
2st International ACCP Pulmonary Board Preparation and Review Course. Athens, 2012.
Training course in bronchoscopy and medical thoracoscopy. Athens, 2012
IPF and Sleep: Common pathways and implications in therapy. Endorsed by the Eu-ropean Respiratory Society, Αthens 2013.
HTS-ERS HERMES Summer School. 2013 Crete, Greece
ERS Seminar: IPF and cancer, 2015 in Athens, Greece
MATCH-GAIN training course certified by ACCP and IASLC, 2015 in Athens
Lung cancer network, January 2016, Athens, Greece

University of Athens Medical School, grade “Excellent”: main topic of research: chronic obstructive pulmonary disease

10/2003 – 1/2006: General Doctor (department of cardiology) Hospital of Pyrgos, Greece
2/2006-10/2007: Scientific associate of 1st Pulmonary Clinic of University of Athens (laboratory of respiratory function)
10/2007-12/2008: Residential in Internal Medicine Sismanogleio General Hospital of Athens, Greece
1/2009-3/2013: Fellowship in Respiratory Medicine: 3nd Pulmonary Department of Sismanogleio General Hospital of Athens, Greece.
6/2013- Pulmonologist in Hygeia Hospital

Clinical Interest:

Research Interest:

Laboratory of respiratory function
Clinical trials (multi-central BIBF in patients with idiopathic pulmonary fibrosis) GCP training-Lisbon, investigator meeting)
Idiopathic pulmonary fibrosis-pulmonary fibrosis due to auto-immune disorders (protocol in collaboration with university of Athens Medical School)

Cardiovascular comorbidities in hospitalized COPD patients: a determinant of future risk? Eur Respir J. 2015 Apr 16.
Prediction of hospitalization stay in COPD exacerbations: the AECOPD-F score. Respir Care. 2014 Nov;59(11):1679-86.
Collateral damage: depressive symptoms in the partners of COPD patients. Lung. 2014 Aug;192(4):519-24.
Impact of Hemodialysis on Dyspnea and Lung Function in End Stage Kidney Disease Patients. BioMed Research International Volume 2014 , Article ID 212751
Driving-related neuropsychological performance in stable COPD patients. Pulmonary Medicine; Vol 2013: Article ID 297371
Prediction of postoperative lung function and chronic dyspnea in lung cancer patients by using quantitative computed tomography. Science Journal of Clinical Medicine July 2013; 2(4): 134-140
The impact of depressive symptoms on recovery and outcome of hospitalized COPD exac-erbations. Eur Respir J 2013; 41:815-823
Pathophysiology of evolution of small airway disease to overt COPD. COPD 2010;7(4):269-75
Pulmonary thromboembolic disease. Review article. Hellenic Journal of cardiology 2012; 530:159-173
Therapeutic dilemma in anti-TB treatment. Pneumon, December 2009;76-78